SOLIGENIX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
SOLIGENIX, INC. (SNGX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.06% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-08-07
- SOLIGENIX, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2021-03-31 was 0.27%.
- SOLIGENIX, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2012 was 0.51%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|
| 2026-06-30 | 4.06% 10-Q · filed 2026-08-07 | |||
| 2025-09-30 | 4.06% 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | 4.06% 10-Q · filed 2025-08-14 | |||
| 2024-12-31 | 4.76% 10-Q · filed 2025-08-14 | |||
| 2024-09-30 | 4.76% 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | 4.76% 10-Q · filed 2024-08-09 | |||
| 2023-09-30 | 3.48% 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | 3.48% 10-Q · filed 2024-08-09 | |||
| 2021-03-31 | 0.27% 10-Q · filed 2022-05-13 | |||
| 2012-12-31 | 0.51% 10-K · filed 2013-02-26 | |||
| 2012-09-30 | 0.51% 10-Q · filed 2012-11-14 | |||
| 2012-06-30 | 0.51% 10-Q · filed 2012-08-10 | |||
| 2011-12-31 | 1.21% 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |